Skip to main content
Clinical Trials/NCT00985010
NCT00985010TerminatedNot Applicable

Manganese, Possible Factor of Higher Mortality in Women With Encephalopathy

Materno-Perinatal Hospital of the State of Mexico1 site in 1 country9 target enrollmentStarted: January 2003Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Sponsor
Enrollment
9
Locations
1
Primary Endpoint
Clinical Evolution

Study Overview

Brief Summary

Objective:

Report manganese serum levels and mortality in encephalopathic patients.

Patients and participants:

Consecutive patients aged > 18 years, with hepatic encephalopathy and informed consent signed by their families.

Interventions:

Patients' clinical characteristics as well as biochemical tests of renal function, hemoglobin, glucose and albumin levels were obtained as well as a blood sample to analyze manganese levels with a graphite furnace atomic absorption spectrometer.

Hypothesis:

There is a difference in the manganese levels between male and female patients.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Consecutive patients aged > 18 years
  • With hepatic encephalopathy
  • Informed consent signed by their families

Exclusion Criteria

  • Portal bypass surgery
  • Cancer of any localization
  • Known malignancy and other severe diseases which shorten life expectancy < 6 months
  • Psychiatric illness

Outcomes

Primary Outcomes

Clinical Evolution

Time Frame: six months

Number of participants who died versus those who remained alive after 6 months of follow up since the first entrance at the Emergency Room

Secondary Outcomes

  • Manganese Levels(Up to six months we followed the recruited patients to determine who were still alive)

Investigators

Sponsor
Materno-Perinatal Hospital of the State of Mexico
Sponsor Class
Other

Study Sites (1)

Loading locations...

Similar Trials

Manganese in Women With Encephalopathy | Clinical Trial